Concepedia

Arja Kaipainen

AK

54

Publications

14K

Citations

43

H-Index

1992

Active since

Affiliations

Harvard University(Current)

Boston Children's Hospital

University of Helsinki

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Arja Kaipainen is an author at Harvard University specializing in medicine, vascular biology, and angiogenesis.

Top concepts

MedicineVascular BiologyAngiogenesisCell BiologyTumor BiologyTumor MicroenvironmentImmunologyCell SignalingPharmacologyCancer Research

Publications per year

1992–2021

54

Publications

54

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Vladimir Joukov, Katri Pajusola, Arja Kaipainen et al. · The EMBO Journal · 1996 · 1.7K citations · Full text

Angiogenesis, Receptor Tyrosine Kinase, Immunology +9

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

Arja Kaipainen, Jaana Korhonen, Tuija Mustonen et al. · Proceedings of the National Academy of Sciences · 1995 · 1.4K citations · Full text

Flt4 Signal, Immunology, Flt4 Mrna +17

Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice

Michael Jeltsch, Arja Kaipainen, Vladimir Joukov et al. · Science · 1997 · 1.3K citations · Full text

Vegf Receptors Vegfr-3, Immunology, Pathology +18

Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

Berit Olofsson, Katri Pajusola, Arja Kaipainen et al. · Proceedings of the National Academy of Sciences · 1996 · 822 citations · Full text

Placenta Growth Factor, Angiogenesis, Developmental Biology +14

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas et al. · Cancer Cell · 2017 · 733 citations · Full text

Urology, Hormonal Receptor, Fibroblast Growth Factor +4

Rows per page

1–5 of 54